CellaVision AB (publ) (OTCMKTS:CLVSF) Stock Price Down 13.2% – Time to Sell?

CellaVision AB (publ) (OTCMKTS:CLVSF – Get Free Report) shares were down 13.2% on Tuesday . The stock traded as low as $14.00 and last traded at $14.00. 1,740 shares traded hands during trading, an increase of 207% from the average daily volume of 567 shares. The stock had previously closed at $16.1350.

CellaVision AB (publ) Price Performance

The firm’s 50 day simple moving average is $13.86 and its 200 day simple moving average is $15.55.

About CellaVision AB (publ)

(Get Free Report)

CellaVision AB (publ), headquartered in Lund, Sweden, is a developer and manufacturer of advanced digital cell morphology solutions for clinical laboratories. The company’s systems automate the preparation, imaging and classification of blood and body fluid slides, enabling laboratory professionals to optimize workflow and improve diagnostic accuracy. CellaVision’s platform is designed to support a broad range of hematology analyses, including white blood cell differentiation, red blood cell morphology assessment and platelet evaluation.

The company’s core offering revolves around its digital microscopy instruments and proprietary software.

See Also

• Five stocks we like better than CellaVision AB (publ)
• MDA Space Targets US Defense Market With $620M Acquisition
• Carnival’s Second Quarter: Is the Stock Still Complicated?
• Domino’s Stock Slides to 52-Week Low as Investors Digest CEO Change
• Microsoft Solves AI’s Biggest Bottleneck With Chevron Deal

Receive News & Ratings for CellaVision AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CellaVision AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.